# Attention Deficit Disorder Medication Response Study

> **NCT01727414** · PHASE4 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 171 (actual)

## Conditions studied

- ADHD - Inattentive Type
- ADHD - Combined Type

## Interventions

- **DRUG:** OROS-Methylphenidate and placebo for inattentive type pts
- **DRUG:** OROS-Methylphenidate and placebo for combined type pts

## Key facts

- **NCT ID:** NCT01727414
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2013-07
- **Final completion:** 2014-07
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2021-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01727414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01727414, "Attention Deficit Disorder Medication Response Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01727414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*